Covalon real-world analysis shows collagen dressing leads in diabetic foot ulcer granulation odds at 8, 12 weeks

• Covalon published a retrospective real-world evidence analysis comparing collagen wound dressings using US Wound Registry data.
• Bayesian ordinal modeling estimated odds of reaching over 50% granulation coverage at 4, 8, 12 weeks.
• Dataset covered 9,452 visit-level wound assessments from U.S. outpatient wound centers.
• In diabetic foot ulcers, Covalon’s collagen matrix dressing ranked highest at 8 and 12 weeks; 12-week probability about triple the next comparator.
• Venous leg ulcer results showed a similar directional pattern; findings were association-based under statistical adjustment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Covalon Technologies Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260924302329) on September 24, 2026, and is solely responsible for the information contained therein.